Stock exchange announcements & investor news
Financial reports
Events & presentations
Stock information
Corporate governance
Dansk information
AGM
Advance your business
Beautiful Biology
About Us
Careers
News
Investors
Get an overview of Novozymes' share price development and analyze the performance.
Novozymes’ stock consists of two types: A and B shares. Both shares have a nominal value of DKK 2 per share, but an A share carries 10 times as many votes as a B share.
Novozymes had more than 60,000 shareholders at the end of 2022, and 76% of the B shares were held outside Denmark, mainly by institutional investors. Fifty institutional investors, including Novo Holdings A/S, held approximately 60% of the B shares. Novo Holdings A/S held 25.6% of the total common stock in Novozymes and controlled 72.7% of the votes.
The Novo Nordisk Foundation wishes to be an “Engaged Owner” in relation to Novozymes and apply engaged ownership objectives and principles which among other things are described in ‘Objectives & Principles for engaged ownership in relation to Novo Nordisk A/S and Novozymes A/S’, cf. www.novonordiskfonden.com. The Novo Nordisk Foundation supports Novozymes in achieving its vision, ensuring competitive financial results and adhering to the Charter for Companies in the Novo Group. All strategic and operational matters are solely decided by the Board and the Executive Management of Novozymes.
OMX Copenhagen 20 CAP OMX Copenhagen 20 OMX Copenhagen Chemicals_GI OMX_Nordic_DKK_PI OMX GES Sustainability Nordic Cap GI
STOXX® Nordic 30 STOXX® 600 Health Care STOXX® 600 ex Eurozone
The Cleantech Index®
UN Global Compact 100 stock index
Names and analyst details of the financial institutions covering Novozymes with equity research.
v.chauhan@alphavalue.eu +91 120 4508000 Sector(s) covered: Medical Technology/Personal care/Gambling-Gaming
2 King Edward St, London EC1A 1HQ
alexander.jones2@bofa.com +44 20 7995 5828 Sector(s) covered: Chemicals
5 The North Colonnade, Canary Wharf, London E14 4BB
sebastian.satz@barclays.com +44 20 3134 7201 Sectors: European Chemicals
60 Threadneedle Street, London EC2R 8HP
sebastian.bray@berenberg.com +44 20 3753 3011 Sectors: chemicals Regions: Europe
50 Berkeley St, London W1J 8HA
gunther.zechmann@bernstein.com +44 20 7170 5019 Sectors: chemicals Regions: Europe
Overgaden Neden Vandet 9B, 1414 Copenhagen
lars.topholm@carnegie.dk +45 3288 0353
Citigroup, 33 Canada Square, Canary Wharf, London E14 5LB
ranulf.orr@citi.com +44 20 7986 3922 Sector(s) covered: Chemicals & Basic Materials
One Cabot Square, London E14 4QJ
samuel.perry@credit-suisse.com +44 207 888 1583 Sectors: Specialty chemicals
Holmens Kanal 2-12, 1092 Copenhagen
thorm@danskebank.dk +45 27 79 29 44 Sectors: Food and Beverage
105/108 Old Broad St, London EC2N 1EN
virginie.boucher-ferte@db.com +44 20 7545 7940 Sectors: chemicals Regions: Europe
Arne Jacobsens Allé 15, 2300 Copenhagen
rune.dahl@dnb.no +45 25 55 01 22
1 Hanover St, London W1S 1YZ
heidi.vesterinen@exanebnpparibas.com +44 20 3430 8439 Sectors: Consumer Ingredients nicola.tang@exanebnpparibas.com +44 7785 740855
Plumtree Court, 25 Shoe Lane, London EC4A 4AU
Georgina.Fraser@gs.com Sector(s) covered: European Chemicals
100 Bishopsgate, London EC2N 4JL
cbentley@jefferies.com +44 20 7029 8000 Sector(s) covered: European Chemicals
25 Bank Street London E14 5JP
chetan.x.udeshi@jpmorgan.com +44 207 742 7034 Sector(s) covered: European Chemicals
Vestergade 8-16 8600 Silkeborg
moen@jyskebank.dk +45 8989 7154
Johannes Vermeerstraat 9 1071 DK Amsterdam
proquas@keplercheuvreux.com +31 20 563 2366
De Entrée 246 1101 EE Amsterdam
rob.hales@morningstar.com +31 20 560 2968 Sectors: chemicals
Groenjordsvej 10, 2300 Copenhagen
Michael.Novod@nordea.com +45 5547 0764
Bernstorffsgade 50, 1577 Copenhagen
soren.samsoe@enskilda.dk +45 3328 3306 Sectors: food, beverages, ingredients and retail Regions: Nordic
5 Broadgate, London EC2M 2QS
charles.eden@ubs.com +44 (0) 20 7568 9622 Sectors: European Chemicals & Consumer
Stay up to date with Investor email alerts.
We encourage all shareholders and investment professionals to contact us, should you have any questions or requests concerning Novozymes.